...
首页> 外文期刊>European journal of neurology: the official journal of the European Federation of Neurological Societies >Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke Scale score during 1-h recombinant tissue-type plasminogen activator infusion
【24h】

Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke Scale score during 1-h recombinant tissue-type plasminogen activator infusion

机译:基于美国国立卫生研究院卒中量表评分,在1小时重组组织型纤溶酶原激活剂输注过程中的简单卒中预后临床预测指标

获取原文
获取原文并翻译 | 示例
           

摘要

Background and purpose: An index for predictors of stroke outcome was determined based on the National Institutes of Health Stroke Scale (NIHSS) scores during 1-h intravenous administration of recombinant tissue-type plasminogen activator (rt-PA). Methods: Stroke patients with baseline NIHSS score ≥8 and occlusion at the internal carotid or middle cerebral arteries (ICA, MCA) were retrospectively studied from a prospective single-center registry. NIHSS scores and inverse change from baseline scores (ΔNIHSS) were assessed at 30 min and 1 h after rt-PA infusion. Patients were divided into two groups according to arterial occlusion sites: group P, ICA or proximal M1; and group D, distal M1 or M2. A modified Rankin Scale score of 2-6 at 3 months was defined as an unfavorable outcome. Results: In all 108 patients, the cutoff NIHSS score predicting unfavorable outcome was ≥12 and cutoff ΔNIHSS scores were ≤2 at both 30 min and 1 h. In group P (n = 36), the cutoff NIHSS score was ≥14 at both 30 min and 1 h and cutoff ΔNIHSS scores were ≤1 at 30 min and ≤2 at 1 h. Unfavorable outcome was seen in all patients with NIHSS1 h ≥ 14, ΔNIHSS30 min ≤ 1 and ΔNIHSS1 h ≤ 2. In group D (n = 72), the cutoff NIHSS scores were ≥12 at both 30 min and 1 h, and cutoff ΔNIHSS scores were ≤2 at 30 min and ≤7 at 1 h; 90% of patients with unfavorable outcome showed ΔNIHSS1 h ≤ 7. Conclusion: NIHSS and ΔNIHSS during 1-h rt-PA infusion seemed predictive of 3-month outcome when the site of arterial occlusion was identified prior to rt-PA.
机译:背景与目的:根据美国国立卫生研究院卒中量表(NIHSS)评分,在静脉内注射重组组织型纤溶酶原激活剂(rt-PA)的过程中,确定卒中预后的指标。方法:从前瞻性单中心登记处回顾性研究基线NIHSS得分≥8且在颈内或中脑动脉(ICA,MCA)闭塞的中风患者。 rt-PA输注后30分钟和1小时评估了NIHSS评分和相对于基线评分的逆变化(ΔNIHSS)。根据动脉闭塞部位将患者分为两组:P组,ICA组或近端M1组。 D组,远端M1或M2。在3个月时改良的Rankin量表评分为2-6被定义为不良结局。结果:在所有108例患者中,在30分钟和1小时时,预测不良结局的临界NIHSS评分≥12,而临界ΔNIHSS分数≤2。在P组(n = 36)中,在30分钟和1 h时NIHSS得分均≥14,在30分钟时ΔNIHSS得分≤1,而1小时时≤2。在所有NIHSS1 h≥14,ΔNIHSS30min≤1和ΔNIHSS1h≤2的患者中均观察到不良结局。在D组(n = 72)中,在30 min和1 h时NIHSS得分均≥12,且ΔNIHSS截止30分钟时得分≤2,1小时时得分≤7; 90%的不良结局患者显示ΔNIHSS1h≤7。结论:在rt-PA之前确定动脉闭塞部位时,在1h rt-PA输注期间NIHSS和ΔNIHSS似乎可预测3个月的结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号